Related references
Note: Only part of the references are listed.Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
Imke Jenniches et al.
BIOLOGICAL PSYCHIATRY (2016)
What are 'good' depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis
Eiko I. Fried et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
Sang-Hun Lee et al.
JOURNAL OF NEUROSCIENCE (2015)
Increased Basolateral Amygdala Pyramidal Cell Excitability May Contribute to the Anxiogenic Phenotype Induced by Chronic Early-Life Stress
Andrew R. Rau et al.
JOURNAL OF NEUROSCIENCE (2015)
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
G. I. Papakostas et al.
MOLECULAR PSYCHIATRY (2015)
From circuits to behaviour in the amygdala
Patricia H. Janak et al.
NATURE (2015)
Ketamine and other potential glutamate antidepressants
Arpan Dutta et al.
PSYCHIATRY RESEARCH (2015)
Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review
G. Fond et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Prostamide F2a receptor antagonism combined with inhibition of FAAH may block the pro- inflammatory mediators formed following selective FAAH inhibition
Alessia Ligresti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials
Farhad Faridhosseini et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses
Teniel S. Ramikie et al.
NEURON (2014)
Neurotherapeutic Implications of Brain-Immune Interactions
Jennifer C. Felger et al.
NEUROPSYCHOPHARMACOLOGY (2014)
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
Amine Bahi et al.
PHYSIOLOGY & BEHAVIOR (2014)
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Daniel J. Hermanson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
Brian C. Shonesy et al.
CELL REPORTS (2014)
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
R. J. Bluett et al.
TRANSLATIONAL PSYCHIATRY (2014)
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Daniel J. Hermanson et al.
NATURE NEUROSCIENCE (2013)
50 years of hurdles and hope in anxiolytic drug discovery
Guy Griebel et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice
Joyonna C. Gamble-George et al.
PSYCHOPHARMACOLOGY (2013)
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Ozge Gunduz-Cinar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
Matthew N. Hill et al.
BIOLOGY OF MOOD & ANXIETY DISORDERS (2013)
Pharmacological enhancement of calcium-activated potassium channel function reduces the effects of repeated stress on fear memory
Derek Atchley et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
Ronald C. Kessler et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2012)
The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder
Piotr Galecki et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
The endocannabinoid system in anxiety, fear memory and habituation
S. Ruehle et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Kelsey C. Duggan et al.
NATURE CHEMICAL BIOLOGY (2011)
Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons
Wei Wang et al.
NEUROPHARMACOLOGY (2011)
Reversible Gating of Endocannabinoid Plasticity in the Amygdala by Chronic Stress: A Potential Role for Monoacylglycerol Lipase Inhibition in the Prevention of Stress-Induced Behavioral Adaptation
Joshua J. Sumislawski et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Plastic Synaptic Networks of the Amygdala for the Acquisition, Expression, and Extinction of Conditioned Fear
Hans-Christian Pape et al.
PHYSIOLOGICAL REVIEWS (2010)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL
Shahin Akhondzadeh et al.
DEPRESSION AND ANXIETY (2009)
Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain
Jian-You Guo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Matthew N. Hill et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Stress-induced neuroinflammation: mechanisms and new pharmacological targets
C. D. Munhoz et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2008)
Identification of basolateral amygdala projection cells and interneurons using extracellular recordings
Ekaterina Likhtik et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: A replication and extension
Maurizio Fava et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2006)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachiclonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons
Nan Sang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice
A Dhir et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test
SC Dulawa et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
The ascent of mouse: Advances in modelling human depression and anxiety
JF Cryan et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects
JB Mangold et al.
DRUG METABOLISM AND DISPOSITION (2004)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice
Z Merali et al.
BIOLOGICAL PSYCHIATRY (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
Anandamide and vanilloid TRPV1 receptors
RA Ross
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Anandamide hydrolysis: a new target for anti-anxiety drugs?
S Gaetani et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
